Maria-Carmela Speranza1, Kazue Kasai1, Sean E Lawler1. 1. Maria-Carmela Speranza, PhD, is a post-doctoral fellow; Kazue Kasai, PhD, is a Research Specialist; and Sean E. Lawler, PhD, is an Assistant Professor in the Harvey Cushing Neurooncology Laboratories in the Department of Neurosurgery at Brigham and Women's Hospital, Harvard Medical School in Boston, Massachusetts.
Abstract
After more than two decades of research and development, oncolytic herpes viruses (oHSVs) are moving into the spotlight due to recent encouraging clinical trial data. oHSV and other oncolytic viruses function through direct oncolytic cancer cell-killing mechanisms and by stimulating antitumor immunity. As further viruses are developed and optimized for the treatment of various types of cancer, appropriate predictive preclinical models will be of great utility. This review will discuss existing data in this area, focusing on the mouse tumor models that are commonly used.
After more than two decades of research and development, oncolytic herpes viruses (oHSVs) are moving into the spotlight due to recent encouraging clinical trial data. oHSV and other oncolytic viruses function through direct oncolytic cancer cell-killing mechanisms and by stimulating antitumor immunity. As further viruses are developed and optimized for the treatment of various types of cancer, appropriate predictive preclinical models will be of great utility. This review will discuss existing data in this area, focusing on the mousetumor models that are commonly used.
Authors: W R Jarnagin; J S Zager; M Hezel; S F Stanziale; P S Adusumilli; M Gonen; M I Ebright; A Culliford; N J Gusani; Y Fong Journal: Cancer Gene Ther Date: 2006-03 Impact factor: 5.987
Authors: Hiroaki Wakimoto; Santosh Kesari; Christopher J Farrell; William T Curry; Cecile Zaupa; Manish Aghi; Toshihiko Kuroda; Anat Stemmer-Rachamimov; Khalid Shah; Ta-Chiang Liu; Deva S Jeyaretna; Jason Debasitis; Jan Pruszak; Robert L Martuza; Samuel D Rabkin Journal: Cancer Res Date: 2009-04-07 Impact factor: 12.701
Authors: U Herrlinger; C M Kramm; K S Aboody-Guterman; J S Silver; K Ikeda; K M Johnston; P A Pechan; R F Barth; D Finkelstein; E A Chiocca; D N Louis; X O Breakefield Journal: Gene Ther Date: 1998-06 Impact factor: 5.250
Authors: Alicia Teijeira Crespo; Stephanie Burnell; Lorenzo Capitani; Rebecca Bayliss; Elise Moses; Georgina H Mason; James A Davies; Andrew J Godkin; Awen M Gallimore; Alan L Parker Journal: Immunology Date: 2021-03-28 Impact factor: 7.215